Wyden, Crapo Announce Finance Markup of Pharmacy Benefit Manager Proposals

Press Release

"This month the Finance Committee will take a critical step to hold drug pricing middlemen accountable and lower costs for Americans at the pharmacy counter. For too long, pharmacy benefit managers have operated without accountability or scrutiny, and the results have been higher drug prices for taxpayers and Americans picking up their prescriptions at the pharmacy counter. Our legislation will build on the legislative framework released this spring to enact commonsense reforms and transparency so drug middlemen work for patients, not the other way around.

Ahead of the markup, as is customary in the Finance Committee, members will be able to offer amendments, and Ranking Member Crapo and I are committed to working with members to incorporate those ideas into a modified Chairman's Mark. Any proposals that are not able to be included in the Mark reported by the committee will continue to be worked on with the goal of incorporating those policies ahead of any action on the Senate floor. I thank Ranking Member Crapo for being a diligent and committed partner in this effort and I look forward to the committee taking bipartisan action to help Americans lower their health costs."

Source